|
1
|
Chen R, Smith-Cohn M, Cohen AL and Colman
H: Glioma subclassifications and their clinical significance.
Neurotherapeutics. 14:284–297. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Delgado-Lopez PD, Corrales-Garcia EM,
Martino J, Lastra-Aras E and Duenas-Polo MT: Diffuse low-grade
glioma: A review on the new molecular classification, natural
history and current management strategies. Clin Transl Oncol.
19:931–944. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duffau H and Taillandier L: New concepts
in the management of diffuse low-grade glioma: Proposal of a
multistage and individualized therapeutic approach. Neuro Oncol.
17:332–342. 2015.PubMed/NCBI
|
|
4
|
Chen X, Zhang M, Gan H, Wang H, Lee JH,
Fang D, Kitange GJ, He L, Hu Z, Parney IF, et al: A novel enhancer
regulates MGMT expression and promotes temozolomide resistance in
glioblastoma. Nat Commun. 9:29492018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schmidt OT and Lademann R: Corilagin, ein
weiterer kristallisierter Gerbstoff aus Dividivi. X. Mitteilung
über natürliche Gerbstoffe. Justus Liebigs Ann Chem. 571:232–237.
1951. View Article : Google Scholar
|
|
6
|
Kakiuchi N, Hattori M, Namba T, Nishizawa
M, Yamagishi T and Okuda T: Inhibitory effect of tannins on reverse
transcriptase from RNA tumor virus. J Nat Prod. 48:614–621. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qiu F, Liu L, Lin Y, Yang Z and Qiu F:
Corilagin inhibits esophageal squamous cell carcinoma by inducing
DNA damage and down-regulation of RNF8. Anticancer Agents Med Chem.
19:1021–1028. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding Y, Ren D, Xu H, Liu W, Liu T, Li L,
Li J, Li Y and Wen A: Antioxidant and pro-angiogenic effects of
corilagin in rat cerebral ischemia via Nrf2 activation. Oncotarget.
8:114816–114828. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu FC, Chaudry IH and Yu HP:
Hepatoprotective effects of corilagin following hemorrhagic shock
are through akt-dependent pathway. Shock. 47:346–345. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo S, Fu Y, Xiong S and Lv J: Corilagin
protects the acute lung injury by ameliorating the apoptosis
pathway. Biomed Pharmacother. 95:1743–1748. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li HR, Liu J, Zhang SL, Luo T, Wu F, Dong
JH, Guo YJ and Zhao L: Corilagin ameliorates the extreme
inflammatory status in sepsis through TLR4 signaling pathways. BMC
Complement Altern Med. 17:182017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu J, Zhang G, Tong Y, Yuan J, Li Y and
Song G: Corilagin induces apoptosis, autophagy and ROS generation
in gastric cancer cells in vitro. Int J Mol Med. 43:967–979.
2019.PubMed/NCBI
|
|
13
|
Deng Y, Li X, Li X, Zheng Z, Huang W, Chen
L, Tong Q and Ming Y: Corilagin induces the apoptosis of
hepatocellular carcinoma cells through the mitochondrial apoptotic
and death receptor pathways. Oncol Rep. 39:2545–2552.
2018.PubMed/NCBI
|
|
14
|
Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang
B, Hu T and Song G: Corilagin inhibits breast cancer growth via
reactive oxygen species-dependent apoptosis and autophagy. J Cell
Mol Med Jun. 22:3795–3807. 2018. View Article : Google Scholar
|
|
15
|
Li N, Lin Z, Chen W, Zheng Y, Ming Y,
Zheng Z, Huang W, Chen L, Xiao J and Lin H: Corilagin from longan
seed: Identification, quantification, and synergistic cytotoxicity
on SKOv3ip and hey cells with ginsenoside Rh2 and 5-fluorouracil.
Food Chem Toxicol. 119:133–140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Milani R, Brognara E, Fabbri E, Finotti A,
Borgatti M, Lampronti I, Marzaro G, Chilin A, Lee KK, Kok SH, et
al: Corilagin induces high levels of apoptosis in the
temozolomide-resistant T98G glioma cell line. Oncol Res.
26:1307–1315. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Noguchi M, Hirata N, Tanaka T, Suizu F,
Nakajima H and Chiorini JA: Autophagy as a modulator of cell death
machinery. Cell Death Dis. 11:5172020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Choi AM, Ryter SW and Levine B: Autophagy
in human health and disease. N Engl J Med. 368:651–662. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baechler BL, Bloemberg D and Quadrilatero
J: Mitophagy regulates mitochondrial network signaling, oxidative
stress, and apoptosis during myoblast differentiation. Autophagy.
15:1606–1619. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang P and Mizushima N: LC3- and
p62-based biochemical methods for the analysis of autophagy
progression in mammalian cells. Methods. 75:13–18. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He F, Ru X and Wen T: NRF2, a
transcription factor for stress response and beyond. Int J Mol Sci.
21:47772020. View Article : Google Scholar
|
|
22
|
Baird L and Yamamoto M: The molecular
mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol.
40:e00099-20. 2020. View Article : Google Scholar
|
|
23
|
Unoki T, Akiyama M and Kumagai Y: Nrf2
activation and its coordination with the protective defense systems
in response to electrophilic stress. Int J Mol Sci. 21:5452020.
View Article : Google Scholar
|
|
24
|
Menegon S, Columbano A and Giordano S: The
dual roles of NRF2 in cancer. Trends Mol Med. 22:578–593. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao Q, Mao A, Yan J, Sun C, Di C, Zhou X,
Li H, Guo R and Zhang H: Downregulation of Nrf2 promotes
radiation-induced apoptosis through Nrf2 mediated Notch signaling
in non-small cell lung cancer cells. Int J Oncol. 48:765–773. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meng QT, Chen R, Chen C, Su K, Li W, Tang
LH, Liu HM, Xue R, Sun Q, Leng Y, et al: Transcription factors Nrf2
and NF-kappaB contribute to inflammation and apoptosis induced by
intestinal ischemia-reperfusion in mice. Int J Mol Med.
40:1731–1740. 2017.PubMed/NCBI
|
|
27
|
Wan ZH, Jiang TY, Shi YY, Pan YF, Lin YK,
Ma YH, Yang C, Feng XF, Huang LF, Kong XN, et al: RPB5-mediating
protein promotes cholangiocarcinoma tumorigenesis and drug
resistance by competing with NRF2 for KEAP1 binding. Hepatology.
71:2005–2022. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitamura H and Motohashi H: NRF2 addiction
in cancer cells. Cancer Sci. 109:900–911. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ji XJ, Chen SH, Zhu L, Pan H, Zhou Y, Li
W, You WC, Gao CC, Zhu JH, Jiang K, et al: Knockdown of
NF-E2-related factor 2 inhibits the proliferation and growth of
U251MG human glioma cells in a mouse xenograft model. Oncol Rep.
30:157–164. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Taguchi K and Yamamoto M: The KEAP1-NRF2
System in Cancer. Front Oncol. 7:852017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang WT, Li GH, Li ZY, Feng S, Liu XQ, Han
GK, Zhang H, Qin XY, Zhang R, Nie QM, et al: Effect of corilagin on
the proliferation and NF-κB in U251 glioblastoma cells and U251
glioblastoma stem-like cells. Evid Based Complement Alternat Med.
2016:14183092016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Basso J, Miranda A, Sousa J, Pais A and
Vitorino C: Repurposing drugs for glioblastoma: From bench to
bedside. Cancer Lett. 428:173–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hau DK, Zhu GY, Leung AK, Wong RS, Cheng
GY, Lai PB, Tong SW, Lau FY, Chan KW, Wong WY, et al: In vivo
anti-tumour activity of corilagin on Hep3B hepatocellular
carcinoma. Phytomedicine. 18:11–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pham AT, Malterud KE, Paulsen BS, Diallo D
and Wangensteen H: DPPH radical scavenging and xanthine oxidase
inhibitory activity of Terminalia macroptera leaves. Nat
Prod Commun. 6:1125–1128. 2011.PubMed/NCBI
|
|
37
|
Gaudreault R and Mousseau N: Mitigating
Alzheimer's disease with natural polyphenols: A review. Curr
Alzheimer Res. 16:529–543. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moraes LS, Donza MR, Rodrigues AP, Silva
BJ, Brasil DS, Zoghbi M, Andrade EH, Guilhon GM and Silva EO:
Leishmanicidal activity of (+)-phyllanthidine and the phytochemical
profile of Margaritaria nobilis (Phyllanthaceae). Molecules.
20:22157–22169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li Y, Xu D, Sun A, Ho SL, Poon CY, Chan
HN, Ng OT, Yung KK, Yan H, Li HW, et al: Fluoro-substituted cyanine
for reliable in vivo labelling of amyloid-β oligomers and
neuroprotection against amyloid-β induced toxicity. Chem Sci.
8:8279–8284. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Adesina SK, Idowu O, Ogundaini AO,
Oladimeji H, Olugbade TA, Onawunmi GO and Pais M: Antimicrobial
constituents of the leaves of Acalypha wilkesiana and
Aacalypha hispida. Phytother Res. 14:371–374. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yeo SG, Song JH, Hong EH, Lee BR, Kwon YS,
Chang SY, Kim SH, Lee SW, Park JH and Ko HJ: Antiviral effects of
Phyllanthus urinaria containing corilagin against human
enterovirus 71 and Coxsackievirus A16 in vitro. Arch Pharm Res.
38:193–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Burapadaja S and Bunchoo A: Antimicrobial
activity of tannins from Terminalia citrina. Planta Med.
61:365–366. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Teodoro GR, Brighenti FL, Delbem AC,
Delbem ÁC, Khouri S, Gontijo AV, Pascoal AC, Salvador MJ and
Koga-Ito CY: Antifungal activity of extracts and isolated compounds
from Buchenavia tomentosa on Candida albicans and
non-albicans. Future Microbiol. 10:917–927. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li X, Deng Y, Zheng Z, Huang W, Chen L,
Tong Q and Ming Y: Corilagin, a promising medicinal herbal agent.
Biomed Pharmacother. 99:43–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Guo YJ, Luo T, Wu F, Liu H, Li HR, Mei YW,
Zhang SL, Tao JY, Dong JH, Fang Y, et al: Corilagin protects
against HSV1 encephalitis through inhibiting the TLR2 signaling
pathways in vivo and in vitro. Mol Neurobiol. 52:1547–1560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Komori A, Yatsunami J, Suganuma M, Okabe
S, Abe S, Sakai A, Sasaki K and Fujiki H: Tumor necrosis factor
acts as a tumor promoter in BALB/3T3 cell transformation. Cancer
Res. 53:1982–1985. 1993.PubMed/NCBI
|
|
47
|
Okabe S, Suganuma M, Imayoshi Y, Taniguchi
S, Yoshida T and Fujiki H: New TNF-alpha releasing inhibitors,
geraniin and corilagin, in leaves of Acer nikoense, Megusurino-ki.
Biol Pharm Bull. 24:1145–1148. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Tong F, Zhang J, Liu L, Gao X, Cai Q, Wei
C, Dong J, Hu Y, Wu G and Dong X: Corilagin attenuates
radiation-induced brain injury in mice. Mol Neurobiol.
53:6982–6996. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lu MC, Ji JA, Jiang ZY and You QD: The
Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic
target: An update. Med Res Rev. 36:924–963. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen HH, Chang HH, Chang JY, Tang YC,
Cheng YC, Lin LM, Cheng SY, Huang CH, Sun MW, Chen CT, et al:
Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated
NRF2 protein acetylation contributes to ABCC1-mediated
chemoresistance and glutathione-mediated survival in acquired
topoisomerase II poison-resistant cancer cells. Free Radic Biol
Med. 113:505–518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Beidler DR, Chang JY, Zhou BS and Cheng
YC: Camptothecin resistance involving steps subsequent to the
formation of protein-linked DNA breaks in human
camptothecin-resistant KB cell lines. Cancer Res. 56:345–353.
1996.PubMed/NCBI
|
|
52
|
Ferguson PJ, Fisher MH, Stephenson J, Li
DH, Zhou BS and Cheng YC: Combined modalities of resistance in
etoposide-resistant human KB cell lines. Cancer Res. 48:5956–5964.
1988.PubMed/NCBI
|
|
53
|
Xu B, Wang S, Li R, Chen K, He L, Deng M,
Kannappan V, Zha J, Dong H and Wang W: Disulfiram/copper
selectively eradicates AML leukemia stem cells in vitro and in vivo
by simultaneous induction of ROS-JNK and inhibition of NF-κB and
Nrf2. Cell Death Dis. 8:e27972017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Yang F, Wang Y, Xue J, Ma Q, Zhang J, Chen
YF, Shang ZZ, Li QQ, Zhang SL and Zhao L: Effect of Corilagin on
the miR-21/smad7/ERK signaling pathway in a schistosomiasis-induced
hepatic fibrosis mouse model. Parasitol Int. 65:308–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhou X, Xiong J, Lu S, Luo L, Chen ZL,
Yang F, Jin F, Wang Y, Ma Q, Luo YY, et al: Inhibitory effect of
corilagin on miR-21-regulated hepatic fibrosis signaling pathway.
Am J Chin Med. 47:1541–1569. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Rami A and Kögel D: Apoptosis meets
autophagy-like cell death in the ischemic penumbra: Two sides of
the same coin? Autophagy. 4:422–426. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Yousefi S, Perozzo R, Schmid I, Ziemiecki
A, Schaffner T, Scapozza L, Brunner T and Simon HU:
Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis.
Nat Cell Biol. 8:1124–1132. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Booth LA, Tavallai S, Hamed HA,
Cruickshanks N and Dent P: The role of cell signalling in the
crosstalk between autophagy and apoptosis. Cell Signal. 26:549–555.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang Z and Guo S: Nrf2/HO-1 mediates the
neuroprotective effect of mangiferin on early brain injury after
subarachnoid hemorrhage by attenuating mitochondria-related
apoptosis and neuroinflammation. Sci Rep. 7:118832017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu J, Zhang L, Li H, Wu S and Liu Z: Nrf2
induced cisplatin resistance in ovarian cancer by promoting CD99
expression. Biochem Biophys Res Commun. 518:698–705. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu P, Rojo de la Vega M, Sammani S,
Mascarenhas JB, Kerins M, Dodson M, Sun X, Wang T, Ooi A, Garcia
JG, et al: RPA1 binding to NRF2 switches ARE-dependent
transcriptional activation to ARE-NRE-dependent repression. Proc
Natl Acad Sci USA. 115:E10352–E10361. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Buendia I, Michalska P, Navarro E, Gameiro
I, Egea J and León R: Nrf2-ARE pathway: An emerging target against
oxidative stress and neuroinflammation in neurodegenerative
diseases. Pharmacol Ther. 157:84–104. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Shaw P and Chattopadhyay A: Nrf2-ARE
signaling in cellular protection: Mechanism of action and the
regulatory mechanisms. J Cell Physiol. 235:3119–3130. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Jiang T, Harder B, Rojo de la Vega M, Wong
PK, Chapman E and Zhang DD: p62 links autophagy and Nrf2 signaling.
Free Radic Biol Med. 88:199–204. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Chen RH, Chen YH and Huang TY:
Ubiquitin-mediated regulation of autophagy. J Biomed Sci.
26:802019. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Narayanan S, Cai CY, Assaraf YG, Guo HQ,
Cui Q, Wei L, Huang JJ, Ashby CR Jr and Chen ZS: Targeting the
ubiquitin-proteasome pathway to overcome anti-cancer drug
resistance. Drug Resist Updat. 48:1006632020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Im E, Yoon JB, Lee HW and Chung KC: Human
telomerase reverse transcriptase (hTERT) positively regulates 26S
proteasome activity. J Cell Physiol. 232:2083–2093. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lokireddy S, Kukushkin NV and Goldberg AL:
cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11
enhances their activity and the degradation of misfolded proteins.
Proc Natl Acad Sci USA. 112:E7176–E7185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Roh JL, Kim EH, Jang H and Shin D: Nrf2
inhibition reverses the resistance of cisplatin-resistant head and
neck cancer cells to artesunate-induced ferroptosis. Redox Biol.
11:254–262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Wang Y, Mandal AK, Son YO, Pratheeshkumar
P, Wise JT, Wang L, Zhang Z, Shi X and Chen Z: Roles of ROS, Nrf2,
and autophagy in cadmium-carcinogenesis and its prevention by
sulforaphane. Toxicol Appl Pharmacol. 353:23–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Kovac S, Angelova PR, Holmström KM, Zhang
Y, Dinkova-Kostova AT and Abramov AY: Nrf2 regulates ROS production
by mitochondria and NADPH oxidase. Biochim Biophys Acta.
1850:794–801. 2015. View Article : Google Scholar : PubMed/NCBI
|
